Literature DB >> 32509227

Analysis of salivary detection of P16INK4A and RASSF1A promoter gene methylation and its association with oral squamous cell carcinoma in a Colombian population.

Leonor-Victoria González-Pérez1, Diana-María Isaza-Guzmán2, Eduin-Alonso Arango-Pérez3, Sergio-Iván Tobón-Arroyave2,4.   

Abstract

BACKGROUND: Epigenetic factors play a fundamental role in the etiopathogenesis of oral squamous cell carcinoma (OSCC). This study evaluated if salivary detection of P16INK4A/RASSF1A gene promoter methylation might be linked to the clinical/histological features of OSCC in a Colombian population.
MATERIAL AND METHODS: Methylation-specific polymerase chain reaction (MSP-PCR) was used to detect the methylation frequency of P16INK4A/RASSF1A genes in DNA obtained from whole saliva collected of 40 healthy controls (HC) and 43 OSCC patients. Determination of the clinical performance of MSP-PCR assay was based on standard algorithms derived from two-way contingency table analysis. The association of methylation status of targeted genes with OSCC was analyzed in a multivariate binary logistic regression model.
RESULTS: There were significantly higher proportions of promoter methylation of these target genes in OSCC patients when compared with HC. The analysis of single methylated genes showed high specificity, good positive and negative predictive values, but was accompanied by a low sensitivity. OSCC cases with clinical stage III/IV, poorly differentiated, and severe cellular atypia showed a significantly greater proportion of methylated than that of unmethylated targeted genes in saliva samples. Logistic regression analysis indicated an independent association of P16INK4A and RASSF1A promoter methylation with OSCC diagnosis. A significant interaction effect between ageing and P16INK4A promoter methylation was also detected.
CONCLUSIONS: Salivary detection of P16INK4A and RASSF1A promoter methylation appears to be independently associated with OSCC and may be linked to the tumor activity in the present population. Consequently, the targeting of these genes in saliva samples might constitute an important tool for diagnosis and prognosis purposes. Key words:Gene methylation, oral squamous cell carcinoma, P16INK4A, RASSF1A, saliva. Copyright:
© 2020 Medicina Oral S.L.

Entities:  

Year:  2020        PMID: 32509227      PMCID: PMC7263777          DOI: 10.4317/jced.56647

Source DB:  PubMed          Journal:  J Clin Exp Dent        ISSN: 1989-5488


  30 in total

1.  A Strong Relationship Between Oral Squamous Cell Carcinoma and DNA Repair Genes.

Authors:  Hakan Avci; Arzu Ergen; Elif Sinem Bireller; Baris Ertugrul; Bedia Cakmakoglu
Journal:  Biochem Genet       Date:  2017-06-21       Impact factor: 1.890

Review 2.  Epigenetics in cancer.

Authors:  Manel Esteller
Journal:  N Engl J Med       Date:  2008-03-13       Impact factor: 91.245

3.  Histomorphometric Analysis of Angiogenesis using CD31 Immunomarker and Mast Cell Density in Oral Premalignant and Malignant Lesions: A Pilot Study.

Authors:  M Jyothsna; M Rammanohar; Kiran Kumar
Journal:  J Clin Diagn Res       Date:  2017-01-01

4.  The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation.

Authors:  Latha Shivakumar; John Minna; Toshiyuki Sakamaki; Richard Pestell; Michael A White
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

5.  Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence.

Authors:  Christian Adrien Righini; Florence de Fraipont; Jean-François Timsit; Claire Faure; Elisabeth Brambilla; Emile Reyt; Marie-Christine Favrot
Journal:  Clin Cancer Res       Date:  2007-02-15       Impact factor: 12.531

6.  Tumor-suppressor Gene Promoter Hypermethylation in Saliva of Head and Neck Cancer Patients.

Authors:  Dmitry A Ovchinnikov; Matthew A Cooper; Pratibala Pandit; William B Coman; Justin J Cooper-White; Patricia Keith; Ernst J Wolvetang; Paul D Slowey; Chamindie Punyadeera
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

7.  Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage.

Authors:  Paulisally Hau Yi Lo; Dan Xie; King Chi Chan; Fang-Ping Xu; Igor Kuzmin; Michael I Lerman; Simon Law; Daniel Chua; Jonathan Sham; Maria Li Lung
Journal:  Cancer Lett       Date:  2007-08-27       Impact factor: 8.679

8.  Patterns of gene promoter methylation in squamous cell cancer of the head and neck.

Authors:  Masayuki Hasegawa; Heather H Nelson; Edward Peters; Elin Ringstrom; Marshall Posner; Karl T Kelsey
Journal:  Oncogene       Date:  2002-06-20       Impact factor: 9.867

9.  Continuous Aging of the Human DNA Methylome Throughout the Human Lifespan.

Authors:  Asa Johansson; Stefan Enroth; Ulf Gyllensten
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

Review 10.  Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy.

Authors:  Madison Canning; Gang Guo; Miao Yu; Calvin Myint; Michael W Groves; James Kenneth Byrd; Yan Cui
Journal:  Front Cell Dev Biol       Date:  2019-04-09
View more
  1 in total

Review 1.  Saliva Gene Promoter Hypermethylation as a Biomarker in Oral Cancer.

Authors:  Óscar Rapado-González; José Luis López-Cedrún; Rafael López-López; Ana María Rodríguez-Ces; María Mercedes Suárez-Cunqueiro
Journal:  J Clin Med       Date:  2021-04-29       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.